Remove ACE Inhibitor Remove Heart Attack Remove Research
article thumbnail

SGLT-2 Inhibitors Show Mixed Results After Heart Attack

DAIC

However, researchers said the drug may be helpful in reducing heart failure risks, including hospitalization, following a heart attack. However, researchers said the drug may be helpful in reducing heart failure risks, including hospitalization, following a heart attack.

article thumbnail

EMPACT-MI Trial Outcomes Reported at ACC24: SGLT-2 Inhibitors Show Mixed Results After Heart Attack

DAIC

While composite of death and heart failure hospitalizations was not significantly reduced, empagliflozin may help reduce heart failure risks after a heart attack, according to results from the EMPACT-MI trial presented on day one of the American College of Cardiology Scientific Sessions, ACC.24,

article thumbnail

Heart Failure – Does Testosterone Hold the Key?

Dr. Sanjay Gupta

Heart failure is a chronic clinical syndrome characterised by the inability of the heart to pump out enough blood to meet the body’s requirements. Heart failure is one of the most researched conditions in all of medicine and happily we now have lots of very beneficial therapies which can improve both quality of life and prognosis.

article thumbnail

What is wrong with the NHS? Part two.

Dr. Malcolm Kendrick

The aim is to reduce death and damage from nasty things such as heart attacks and strokes. With diabetes, the aim is also to reduce heart attacks and strokes… additionally kidney failure, and amputations, and blindness. Currently, after any heart attack, standard therapy includes four different medications.